Parasitic worms and inflammatory diseases

Abstract

SUMMARY The debate on whether infection precipitates or prevents autoimmunity remains a contentious one. Recently the suggestion that some unknown microbe can be at the origin of some chronic inflammatory diseases has been countered by accumulating evidence that decreasing infection rates might have an important role to play in the rising prevalence of autoimmune disorders. The ‘Hygiene Hypothesis’ was initially postulated to explain the inverse correlation between the incidence of infections and the rise of allergic diseases, particularly in the developed world. Latterly, the Hygiene Hypothesis has been extended to also incorporate autoimmune diseases in general. Amongst the various infectious agents, a particular emphasis has been put on the interaction between parasitic worms and humans. Worm parasites have co‐evolved with the mammalian immune system for many millions of years and during this time, they have developed extremely effective strategies to modulate and evade host defences and so maintain their evolutionary fitness. It is therefore reasonable to conclude that the human immune system has been shaped by its relationship with parasitic worms and this may be a necessary requirement for maintaining our immunological health. Fully understanding this relationship may lead to novel and effective treatments for a host of deleterious inflammatory reactions.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 73

1. 1.

   Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353-3361.

   Not in our library10.2337/diabetes.51.12.3353

2. 2.

   Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104:182-191.

   Not in our library10.1016/s0303-8467(02)00036-7

3. 3.

   Kim MS, Polychronakos C. Immunogenetics of type 1 diabetes. Horm Res. 2005;64:180-188.

   Not in our library10.1159/000089190

4. 4.

   Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br Med J. 1995;311:913-917.

   Not in our library10.1136/bmj.311.7010.913

5. 5.

   Strachan DP. Hay fever, hygiene, and household size. Br Med J. 1989;299:1259-1260.

   Not in our library10.1136/bmj.299.6710.1259

6. 6.

   Chan-Yeung M, et al. The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China. Eur Respir J. 2002;19:853-858.

   Not in our library10.1183/09031936.02.00250602

7. 7.

   Perzanowski MS, et al. Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr. 2002;140:582-588.

   Not in our library10.1067/mpd.2002.122937

8. 8.

   Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol. 2005;5:420-426.

   Not in our library10.1038/nri1601

9. 9.

   Weinstock JV, et al. The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med. 2002;139:334-338.

   Not in our library10.1067/mlc.2002.124343

10. 10.

    Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol. 2005;26:260-267.

    Not in our library10.1016/j.it.2005.03.009

11. 11.

    Cooke A, et al. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol. 2004;20:316-321.

    Not in our library10.1016/j.pt.2004.04.010

12. 12.

    Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-920.

    Not in our library10.1056/nejmra020100

13. 13.

    Wilfing A, et al. African–European differences in the capacity of T-cell cytokine production. Am J Trop Med Hyg. 2001;65:504-509.

    Not in our library10.4269/ajtmh.2001.65.504

14. 14.

    Banting FG, Best CH. Pancreatic extracts. 1922. J Lab Clin Med. 1990;115:254-272.

    Not in our library

15. 15.

    She JX. Susceptibility to type I diabetes: HLA-DQ DR revisited. Immunol Today. 1996;17:323-329.

    Not in our library10.1016/0167-5699(96)10014-1

16. 16.

    Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today. 1990;11:122-129.

    Not in our library10.1016/0167-5699(90)90049-f

17. 17.

    Papadopoulos GK. Genetics of type I diabetes. Immunol Today. 1998;19:288-289.

    Not in our library10.1016/s0167-5699(98)01271-7

18. 18.

    Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J Clin Endocrinol Metab. 2006.

    Not in our library10.1210/jc.2005-1679

19. 19.

    Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355:873-876.

    Not in our library

20. 20.

    Marrosu MG, et al. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet. 2004;13:2919-2924.

    Not in our library10.1093/hmg/ddh319

21. 21.

    Joner G, Stene LC, Sovik O. Nationwide, prospective registration of type 1 diabetes in children aged < 15 years in Norway 1989–98: no increase but significant regional variation in incidence. Diabetes Care. 2004;27:1618-1622.

    Not in our library10.2337/diacare.27.7.1618

22. 22.

    Moussa MA, et al. Prevalence of type 1 diabetes among 6- to 18-year-old Kuwaiti children. Med Princ Pract. 2005;14:87-91.

    Not in our library10.1159/000083917

23. 23.

    Moussa MA, et al. Factors associated with type 1 diabetes in Kuwaiti children. Acta Diabetol. 2005;42:129-137.

    Not in our library10.1007/s00592-005-0192-0

24. 24.

    Ionescu-Tirgoviste C, et al. An increasing trend in the incidence of type 1 diabetes mellitus in children aged 0–14 years in Romania – ten years (1988–97) EURODIAB study experience. J Pediatr Endocrinol Metab. 2004;17:983-991.

    Not in our library10.1515/jpem.2004.17.7.983

25. 25.

    Makino S, et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29:1-13.

    Not in our library10.1538/expanim1978.29.1_1

26. 26.

    Leiter EH, Serreze DV, Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today. 1990;11:147-149.

    Not in our library10.1016/0167-5699(90)90057-g

27. 27.

    Hutchings P, et al. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 1990;348:639-642.

    Not in our library10.1038/348639a0

28. 28.

    Rosmalen JG, et al. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes. Adv Exp Med Biol. 1997;417:291-294.

    Not in our library10.1007/978-1-4757-9966-8_47

29. 29.

    Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 1992;51:285-322.

    Not in our library10.1016/s0065-2776(08)60490-3

30. 30.

    Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. 1988;239:500-502.

    Not in our library10.1126/science.3277269

31. 31.

    Cooke A, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999;21:169-176.

    Not in our library10.1046/j.1365-3024.1999.00213.x

32. 32.

    Zaccone P, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol. 2003;33:1439-1449.

    Not in our library10.1002/eji.200323910

33. 33.

    Baxter AG, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 1994;83:227-231.

    Not in our library

34. 34.

    Bras A, Aguas AP. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology. 1996;89:20-25.

    Not in our library10.1046/j.1365-2567.1996.d01-717.x

35. 35.

    Zaccone P, et al. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol. 2004;34:3246-3256.

    Not in our library10.1002/eji.200425285

36. 36.

    Wilberz S, et al. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 1991;34:2-5.

    Not in our library10.1007/bf00404016

37. 37.

    Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003;3:733-744.

    Not in our library10.1038/nri1183

38. 38.

    Maizels RM, et al. Helminth parasites – masters of regulation. Immunol Rev. 2004;201:89-116.

    Not in our library10.1111/j.0105-2896.2004.00191.x

39. 39.

    van Die I, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology. 2003;13:471-478.

    Not in our library10.1093/glycob/cwg052

40. 40.

    van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003;3:697-709.

    Not in our library10.1038/nri1182

Cited by papers we hold 2

• Training the Fetal Immune System Through Maternal Inflammation—A Layered Hygiene Hypothesis · 2020
  Not checked
• Helminth Immunomodulation in Autoimmune Disease · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.